Zhang X - Search Results

1

Diagnosis and Treatment of Rheumatic Adverse Events Related to Immune Checkpoint Inhibitors.

Xiao Y, Zeng L, Shen Q, Zhou Z, Mao Z, Wang Q, Zhang X, Li Y, Yao W. Xiao Y, et al. Among authors: zhang x. J Immunol Res. 2020 Aug 4;2020:2640273. doi: 10.1155/2020/2640273. eCollection 2020. J Immunol Res. 2020. PMID: 32832568 Free PMC article. Review.

2

Intratumoral injection of dendritic cells overexpressing interleukin‑12 inhibits melanoma growth.

Yao W, Li Y, Zeng L, Zhang X, Zhou Z, Zheng M, Wan H. Yao W, et al. Among authors: zhang x. Oncol Rep. 2019 Jul;42(1):370-376. doi: 10.3892/or.2019.7165. Epub 2019 May 21. Oncol Rep. 2019. PMID: 31115558

3

Cyclin-dependent kinase 15 upregulation is correlated with poor prognosis for patients with breast cancer.

Zhang X, Wang Q, Luo Y, Song M, Zhou Z, Zeng L, Hu M, Yang C. Zhang X, et al. J Int Med Res. 2021 Jun;49(6):300060521999552. doi: 10.1177/0300060521999552. J Int Med Res. 2021. PMID: 34162268 Free PMC article.

4

Crizotinib versus Alectinib for the Treatment of ALK-Positive Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.

Zeng Q, Zhang X, He S, Zhou Z, Xia L, Zhang W, Zeng L. Zeng Q, et al. Among authors: zhang w, zhang x. Chemotherapy. 2022;67(2):67-80. doi: 10.1159/000521452. Epub 2021 Dec 14. Chemotherapy. 2022. PMID: 34915469

5

Patients with metastatic renal cell carcinoma who receive immune-targeted therapy may derive survival benefit from nephrectomy.

Dong H, Cao Y, Jian Y, Lei J, Zhou W, Yu X, Zhang X, Peng Z, Sun Z. Dong H, et al. Among authors: zhang x. BMC Cancer. 2023 Oct 6;23(1):943. doi: 10.1186/s12885-023-11408-x. BMC Cancer. 2023. PMID: 37803307 Free PMC article.

6

TBC1D10B promotes tumor progression in colon cancer via PAK4‑mediated promotion of the PI3K/AKT/mTOR pathway.

Chi XJ, Song YB, Zhang H, Wei LQ, Gao Y, Miao XJ, Yang ST, Lin CY, Lan D, Zhang X. Chi XJ, et al. Among authors: zhang h, zhang x. Apoptosis. 2024 Aug;29(7-8):1185-1197. doi: 10.1007/s10495-024-01972-3. Epub 2024 Jun 2. Apoptosis. 2024. PMID: 38824479

7

UNC0638, a G9a inhibitor, suppresses epithelial‑mesenchymal transition‑mediated cellular migration and invasion in triple negative breast cancer.

Liu XR, Zhou LH, Hu JX, Liu LM, Wan HP, Zhang XQ. Liu XR, et al. Mol Med Rep. 2018 Feb;17(2):2239-2244. doi: 10.3892/mmr.2017.8190. Epub 2017 Nov 29. Mol Med Rep. 2018. PMID: 29207160 Free PMC article.

8

[Construction of regional ecological security pattern based on the "sensitivity-importance-connectivity" framework: A case study of Guizhou Province].

Gao ZQ, Li CB, Yang ZY, Wang YF, Shen N, Zhang XY, Li MJ, Liu YW. Gao ZQ, et al. Among authors: zhang xy. Ying Yong Sheng Tai Xue Bao. 2024 Oct;35(10):2822-2832. doi: 10.13287/j.1001-9332.202410.019. Ying Yong Sheng Tai Xue Bao. 2024. PMID: 39727129 Chinese.

9

[Changes of climate niche of Solidago canadensis during its invasion in China].

Zhang XR, Li XD, Chen Y, Zhang CL, Wang J, Song XJ, Song YH, Liu G. Zhang XR, et al. Ying Yong Sheng Tai Xue Bao. 2024 Oct;35(10):2707-2714. doi: 10.13287/j.1001-9332.202410.001. Ying Yong Sheng Tai Xue Bao. 2024. PMID: 39727117 Chinese.

10

[Comprehensive evaluation of resistance to Cd stress in mycorrhizal seedlings formed by different genotypes of Cenococcum geophilum and Pinus massoniana].

Zhang X, Yan TY, Zhang YH, Wu AL, Xie RZ, Zhang TX, Yang WH. Zhang X, et al. Ying Yong Sheng Tai Xue Bao. 2024 Oct;35(10):2677-2687. doi: 10.13287/j.1001-9332.202410.008. Ying Yong Sheng Tai Xue Bao. 2024. PMID: 39727114 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

182,340 results

Search Page

Filters